When administered by a licensed provider, these treatments complement each other safely and effectively
Clinical trials report an average of 1215% body weight reduction in patients using GLP-1 drugs like Wegovy and Mounjaro
doi: 10.1056/NEJMoa1916038 98 PetriKCCIngwersenSHFlintAZachoJOvergaardRV
A provider will review your online form and consultation results to determine whether you are a good candidate for treatment
The study of more than 111,000 women found that those who took popular GLP-1 drugs prescribed for obesity or diabetes had a more than 30% lower risk of breast cancer, though the researchers cautioned that the observational study doesnt prove the popular weight-loss drugs reduce cancer risk
We have to be very careful with brands coming in and saying, Oh, I have something that could potentially help the GLP-1 pathway, so were going to call this the GLP-1 [supplement]. Or, I have something that could maybe reduce your hunger a little bit